Location History:
- Monterey, CA (US) (1978)
- Hendersonville, NC (US) (1994)
- Redmond, WA (US) (1992 - 2011)
- Banning, CA (US) (2020)
Company Filing History:
3 out of 7 
2 out of 4 
1 out of 21 
Years Active: 1978-2020
Title: Inventor Spotlight: Richard E. Herman
Introduction
Richard E. Herman, an accomplished inventor based in Redmond, Washington, has made significant contributions to the field of biochemistry and molecular biology. With a total of seven patents to his name, his innovative works center around the development of novel polypeptides that play pivotal roles in various biological applications.
Latest Patents
One of Richard's latest patents involves the disclosure of "Phage Displayed Trp Cage Ligands," which encompasses Trp cage binding domains polypeptides characterized by specific generic formulae, including SEQ ID NO: 2, 7, 10, or 11. These binding domains can be efficiently produced and screened through advanced phage display technology. Another notable patent focuses on "Phage Displayed Cell Binding Peptides," detailing the construction, expression, and selection of mutated genes that encode innovative Trp cage polypeptides with desirable binding properties. Notably, the targets of these polypeptides extend beyond mere proteins or polypeptides; they may include a variety of biological or synthetic macromolecules, organic and inorganic substances, and potentially distinct cell or tissue types. This invention achieves the creation of genetic variants of Trp cage-encoding nucleic acids through controlled random mutagenesis, resulting in a diverse mixture of polypeptides capable of binding various targets.
Career Highlights
Throughout his career, Richard E. Herman has held positions at reputable firms, including Bio Techniques Laboratories, Inc. and Moderna, Inc. His expertise and innovative thinking have driven forward research and development in the biotechnological space, contributing to advancements that have the potential to impact the health and life sciences industries significantly.
Collaborations
Richard has worked alongside prominent colleagues, including Douglas L. Badders and Douglas R. Ware. These collaborations exemplify the importance of teamwork in driving innovation and achieving breakthroughs in scientific research.
Conclusion
Richard E. Herman's dedication to innovation and his impressive portfolio of patents demonstrate his commitment to advancing technology in biochemistry. His work with Trp cage polypeptides offers exciting possibilities for future research and applications in various scientific fields. As he continues to push the boundaries of invention, Richard E. Herman remains a notable figure in the world of biotechnology.